These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16204389)

  • 1. Combined estradiol/gestodene and acute pancreatitis.
    Trenque-Tessereau MG; Picot C; Herment N; Trenque TC
    Ann Pharmacother; 2005 Nov; 39(11):1953-4. PubMed ID: 16204389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our 3- to 5-year experience with Anteovin].
    Pŭnevska M; Veltova L; Vlasova D
    Akush Ginekol (Sofiia); 1999; 38(2):54-5. PubMed ID: 10730393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive-induced central retinal artery occlusion.
    Rekhi GS; Dheer S
    J Assoc Physicians India; 2002 Aug; 50():1084-5. PubMed ID: 12421041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 5. Lybrel--a continuous oral contraceptive.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):61-2. PubMed ID: 17652998
    [No Abstract]   [Full Text] [Related]  

  • 6. Femodene/Minulet--how different is gestodene?
    Drug Ther Bull; 1990 May; 28(11):41-2. PubMed ID: 2131208
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives and the risk of breast cancer.
    Grant EC
    N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
    [No Abstract]   [Full Text] [Related]  

  • 9. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
    Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
    Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports.
    Elouni B; Ben Salem C; Zamy M; Ganne N; Beaugrand M; Bouraoui K; Biour M
    Ann Pharmacother; 2010 Dec; 44(12):2035-7. PubMed ID: 21119102
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical treatment of a uterine arteriovenous malformation.
    Khatree MH; Titiz H
    Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):378-80. PubMed ID: 10554961
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients.
    Kline RM; Fennewald L; Vore M; Bertolone SJ; Hente ML
    J Pediatr Hematol Oncol; 1999; 21(5):436-40. PubMed ID: 10524461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive.
    Kunzmann S; Kullak-Ublick GA; Greiner A; Jeschke R; Hebestreit H
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):596-9. PubMed ID: 15861022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Minisiston as a contraceptive for adolescents].
    Havlín M
    Ceska Gynekol; 1997 Dec; 62 Suppl():19-20. PubMed ID: 9601711
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal and posthysterectomy osteoporosis. December 1,2000].
    Racheva E; Georgiev D; Karag'ozov I; Stamenov G;
    Akush Ginekol (Sofiia); 2001; 41(1):28-31. PubMed ID: 11519305
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex hormones and thrombosis.
    Watson HG
    Semin Hematol; 2007 Apr; 44(2):98-105. PubMed ID: 17433902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peliosis hepatis revealed by biliary colic in a patient with oral contraceptive use.
    Hung NR; Chantrain L; Dechambre S
    Acta Chir Belg; 2004; 104(6):727-9. PubMed ID: 15663284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hormone replacement therapy controversy.
    Lumsden M
    BJOG; 2005 Jun; 112(6):689-91. PubMed ID: 15924520
    [No Abstract]   [Full Text] [Related]  

  • 20. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.